"Tumor marker"의 두 판 사이의 차이
| 8번째 줄: | 8번째 줄: | ||
*[[CA-125]]: [[ovarian cancer]], [[endometrial cancer]], fallopian tube cancer, [[lung cancer]], breast cancer and gastrointestinal cancer, [[endometriosis]] | *[[CA-125]]: [[ovarian cancer]], [[endometrial cancer]], fallopian tube cancer, [[lung cancer]], breast cancer and gastrointestinal cancer, [[endometriosis]] | ||
**[[endometriosis]]: 재발의 지표 | **[[endometriosis]]: 재발의 지표 | ||
| + | **[[HE4]]: [[ovarian cancer]] | ||
*[[Carcinoembryonic antigen]]([[CEA]]): gastrointestinal cancer, [[cervix cancer]], lung cancer, ovarian cancer, breast cancer, urinary tract cancer | *[[Carcinoembryonic antigen]]([[CEA]]): gastrointestinal cancer, [[cervix cancer]], lung cancer, ovarian cancer, breast cancer, urinary tract cancer | ||
**Colorectal cancer: 재발의 예후인자, 치료효과 판정, 재발 추적 | **Colorectal cancer: 재발의 예후인자, 치료효과 판정, 재발 추적 | ||
*[[Prostate-specific antigen]]([[PSA]]): [[prostate cancer]] | *[[Prostate-specific antigen]]([[PSA]]): [[prostate cancer]] | ||
*[[Calcitonin]]: [[medullary thyroid carcinoma]] | *[[Calcitonin]]: [[medullary thyroid carcinoma]] | ||
2022년 4월 29일 (금) 08:45 판
종양표지자(tumor marker, 암표지자)는 보통 선별검사로서의 가치는 떨어지나 재발의 추적, 수술의 성공 여부 등을 판단하는데 이용된다.
종류
- Alpha fetoprotein(AFP): germ cell tumor, hepatocellular carcinoma, hepatoblastoma
- CA15-3: breast cancer
- CA19-9: pancreatic cancer, colorectal cancer, 기타 gastrointestinal cancer
- CA-125: ovarian cancer, endometrial cancer, fallopian tube cancer, lung cancer, breast cancer and gastrointestinal cancer, endometriosis
- endometriosis: 재발의 지표
- HE4: ovarian cancer
- Carcinoembryonic antigen(CEA): gastrointestinal cancer, cervix cancer, lung cancer, ovarian cancer, breast cancer, urinary tract cancer
- Colorectal cancer: 재발의 예후인자, 치료효과 판정, 재발 추적
- Prostate-specific antigen(PSA): prostate cancer
- Calcitonin: medullary thyroid carcinoma